Last reviewed · How we verify
DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE
Brief Summary: Some colorectal liver metastases can only be resected after inducing liver regeneration by portal vein embolization (PVE) to increase size function of the future liver remnant (FLR). While PVE is standard, embolization of portal vein and hepatic veins (PVE/HVE) on one side of the liver may faster and more extensive liver size and function growth. PVE/HVE is a novel procedure and requires a safety and feasibility evaluation in a pretrial (DRAGON1) to then be compared in a randomized controlled trial (RCT) to PVE (DRAGON 2).
Details
| Lead sponsor | Maastricht University |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 111 |
| Start date | Fri May 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Colorectal Cancer Liver Metastases
Interventions
- Portal and Hepatic Vein Embolization
Countries
Italy, Netherlands, Belgium, Austria, Sweden, United Kingdom, Germany, Norway, Canada, Switzerland, Australia, United States, Spain